Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8058 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7763 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7676 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7634 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7379 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7368 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7365 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7346 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7279 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7259 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7251 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7194 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD1238 |
Approved |
0.7125 |
Intermediate Similarity |
NPD37 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7095 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7052 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD164 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7610 |
Discontinued |
0.6994 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6975 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7819 |
Suspended |
0.6968 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6963 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5406 |
Approved |
0.6928 |
Remote Similarity |
NPD5405 |
Approved |
0.6928 |
Remote Similarity |
NPD2438 |
Suspended |
0.6928 |
Remote Similarity |
NPD5404 |
Approved |
0.6928 |
Remote Similarity |
NPD5408 |
Approved |
0.6923 |
Remote Similarity |
NPD7228 |
Approved |
0.6912 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6903 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6879 |
Remote Similarity |
NPD8313 |
Approved |
0.6879 |
Remote Similarity |
NPD8312 |
Approved |
0.6875 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.687 |
Remote Similarity |
NPD7798 |
Approved |
0.6867 |
Remote Similarity |
NPD6663 |
Approved |
0.6867 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD3750 |
Approved |
0.6848 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6835 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD5402 |
Approved |
0.6824 |
Remote Similarity |
NPD5736 |
Approved |
0.6821 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD2796 |
Approved |
0.6818 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6815 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD2534 |
Approved |
0.6792 |
Remote Similarity |
NPD2532 |
Approved |
0.6792 |
Remote Similarity |
NPD2533 |
Approved |
0.679 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6779 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6774 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6768 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD7240 |
Approved |
0.6763 |
Remote Similarity |
NPD6764 |
Approved |
0.6763 |
Remote Similarity |
NPD6765 |
Approved |
0.6748 |
Remote Similarity |
NPD7411 |
Suspended |
0.6735 |
Remote Similarity |
NPD5667 |
Approved |
0.673 |
Remote Similarity |
NPD6799 |
Approved |
0.6728 |
Remote Similarity |
NPD3226 |
Approved |
0.6727 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6727 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD1929 |
Approved |
0.6716 |
Remote Similarity |
NPD1930 |
Approved |
0.6712 |
Remote Similarity |
NPD3972 |
Approved |
0.6711 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6708 |
Remote Similarity |
NPD5403 |
Approved |
0.6707 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6688 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6687 |
Remote Similarity |
NPD5401 |
Approved |
0.6687 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5909 |
Discontinued |
0.6667 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6667 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6667 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6647 |
Remote Similarity |
NPD3749 |
Approved |
0.6646 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6646 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.6646 |
Remote Similarity |
NPD6385 |
Approved |
0.6646 |
Remote Similarity |
NPD6386 |
Approved |
0.6645 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6645 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6645 |
Remote Similarity |
NPD7715 |
Approved |
0.6645 |
Remote Similarity |
NPD7714 |
Approved |
0.6644 |
Remote Similarity |
NPD1281 |
Approved |
0.6641 |
Remote Similarity |
NPD1989 |
Approved |
0.663 |
Remote Similarity |
NPD6535 |
Approved |
0.663 |
Remote Similarity |
NPD6534 |
Approved |
0.6627 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6623 |
Remote Similarity |
NPD7095 |
Approved |
0.6622 |
Remote Similarity |
NPD1876 |
Approved |
0.6621 |
Remote Similarity |
NPD17 |
Approved |
0.6619 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6615 |
Remote Similarity |
NPD1202 |
Approved |
0.6613 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6612 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6612 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.661 |
Remote Similarity |
NPD6784 |
Approved |
0.661 |
Remote Similarity |
NPD6785 |
Approved |
0.6609 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD919 |
Approved |
0.6606 |
Remote Similarity |
NPD1934 |
Approved |
0.6605 |
Remote Similarity |
NPD920 |
Approved |
0.6599 |
Remote Similarity |
NPD6637 |
Approved |
0.6597 |
Remote Similarity |
NPD9545 |
Approved |
0.6597 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6588 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6585 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6584 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6581 |
Remote Similarity |
NPD2569 |
Approved |
0.6581 |
Remote Similarity |
NPD2567 |
Approved |
0.6579 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6579 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6579 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6578 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6578 |
Remote Similarity |
NPD8319 |
Approved |
0.6561 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6561 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6561 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6561 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6561 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6558 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6558 |
Remote Similarity |
NPD1933 |
Approved |
0.6552 |
Remote Similarity |
NPD5585 |
Approved |
0.6552 |
Remote Similarity |
NPD3025 |
Approved |
0.6552 |
Remote Similarity |
NPD3024 |
Approved |
0.655 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.655 |
Remote Similarity |
NPD5242 |
Approved |
0.6548 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6533 |
Remote Similarity |
NPD2798 |
Approved |
0.6532 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6532 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6527 |
Remote Similarity |
NPD5353 |
Approved |
0.6519 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD6039 |
Approved |
0.6512
|
Remote Similarity |
NPD6166 |
Phase 2 |